An endurance horse who finished second in an 80-kilometre CEI1* race in Jordan in May has tested positive for an anabolic steroid and three other controlled medications, as well as a metabolite of one of the drugs.
Provisional suspensions have been imposed on the rider, Nayef Al Fayez, who is registered in Jordan, and the horse Obama Al Aswad.
The pair were competing in the race in Amman on May 21.
The FEI said in a statement that Obama Al Aswad tested positive for the banned substance boldenone, and the controlled medications dexamethasone, meloxicam, and phenylbutazone, and phenylbutazone’s metabolic byproduct oxyphenbutazone.
Boldenone is an anabolic steroid listed as a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations.
Dexamethasone is a corticosteroid used to treat inflammatory and auto-immune conditions, while the non-steroidal anti-inflammatory drugs meloxicam and phenylbutazone are used for pain relief.
The provisional suspension was imposed on Al Fayez on June 20. A two-month provisional suspension on the horse applies from the same date.